Healthcare organizations don't need more isolated initiatives. They need to strengthen their organizational capabilities to execute their strategy with excellence.
We work with patient foundations, hospitals, nursing organizations, the pharmaceutical industry, and partner consulting firms to match needs with structured solutions
We build with you, driving better outcomes for patients
TRIA: Structuring Compliant Pharma-Patient Organization Alliances
SHAR: Strategic diagnosis and maturity assessment for patient programs (8 weeks)
PULSE: Strategic support and sustainability monitoring in healthcare
Understand the operational health of your initiative before making investment or scaling decisions.
Over the course of eight weeks, SHAR analyzes bottlenecks in the patient journey, compliance gaps, and adherence leakage to build a data-driven executive roadmap.
SHAR is a strategic diagnostic tool for healthcare organizations and the pharmaceutical industry that need to evaluate a program, care pathway, or capability before deciding how to strengthen or scale it.
Trayelia listens to teams, reviews processes and metrics, and evaluates the interconnections between people, governance, resources, technology, and the patient experience. We translate these findings into clear priorities.
PULSE Support Framework:
Quarterly Progress Reviews: Periodic monitoring of continuity and adherence indicators; analysis of retention KPIs, patient volume, and satisfaction.
Rapid Response Committee: Strategic guidance to resolve access or operational bottlenecks.
Progressive Optimization: Ongoing identification of opportunities for organizational evolution to scale operations across regions or medical conditions.
From shared intent to demonstrable impact.
We act as an independent intermediary between the pharmaceutical industry and patient organizations to design and execute projects with clear objectives, fund traceability, and robust evidence. Patient organizations have intimate knowledge of their community's needs. Pharmaceutical companies want to support relevant initiatives and understand their outcomes.
TRIA connects the pharmaceutical industry, patient organizations, and Trayelia around a common purpose. We act as an intermediary: helping to structure the initiative, preparing teams to carry it out, and supporting the monitoring of results.
Three stakeholders. One purpose. Demonstrable impact.
Keep your finger on the pulse of your strategy in a changing environment.
We offer an external executive perspective that supports project implementation, identifies deviations early, and adjusts the operational course before results are impacted.
PULSE maintains an external strategic view of this process. Through advisory conversations and capability assessments.
Trayelia helps leaders interpret unfolding events, weigh options, and recognize in time where adjustments are needed.
When do you need SHAR?
Benefits of TRIA
Governance and Transparency: Clear separation between sponsorship and operational autonomy, aligned with industry regulations.
Demonstrable Results: Definition of KPIs and social impact indicators prior to implementation, with ongoing tracking to substantiate results to pharmaceutical steering committees.
Operational Efficiency: Trayelia manages coordination and monitoring, allowing both parties to remain focused on their key objectives.
DIAGNOSIS & STRATEGIC AUDIT (8 WEEKS)
NEUTRAL COORDINATION AND GOVERNANCE
ONGOING SUPPORT AND AUDITING
You have multiple opportunities for improvement and need to make a rational decision on where to focus strategic resources for the upcoming cycle (Healthcare ROI).
Budget prioritization
There are unidentified bottlenecks in access, authorizations, or follow-up that delay the start of treatment (time-to-treatment).
Capacity building within the Foundation or for a project third party.
You invested in technology or a CRM, yet your teams lack operational alignment or integrated metrics, and artificial intelligence is not being utilized in compliance with pharma regulations.
Friction in the patient journey
Technological or equipment fragmentation
Your care program or pathway is operational, but adherence and persistence rates do not reflect the resources invested; premature treatment discontinuation is occurring, and patient outcomes are being affected.
What does the project steering committee receive?
Initiative Maturity Assessment: A quantitative diagnosis covering process governance, technology, patient experience governance, and compliance with pharmaceutical industry guidelines.
Adherence Gap and Attrition Map: Precise identification of the critical points where patients drop out of the process or treatment.
Prioritization Matrix & 12-Month Roadmap: A sequenced roadmap featuring recommended initiatives, assigned responsibilities, tracking metrics (KPIs), and projected impact on patient retention.
You notice that a project has lost momentum or that there are training gaps within the operational team.
The pharmaceutical company requires guarantees of transparency and a neutral governance framework to support the collaboration..
It is necessary to demonstrate with real data what was achieved with the resources provided and how the community's quality of life improved.
Results below the investment
Lack of structure in patient initiatives
Compliance and independence requirements
Need for evidence and impact
A genuine need has been identified by a patient association, but this has not yet translated into a technical project with a defined methodology and budget; expectations need to be aligned.
You have completed the SHAR phase and want to track the action plan for rigorous practical execution, or operational metrics indicate a drop in participation or process slowdowns following the launch
Regulatory changes, the entry of new players, or internal shifts require adapting the strategy without halting operations.
The patient organization seeks to professionalize its management in order to execute long-term, sustainable projects.
You need to validate complex decisions with an independent ally who is an expert in the sector.
When should a TRIA be activated?
When should PULSE accompaniment be activated?
Our Approach
The Trayelia method: Structured Transformation for Health Projects
1
Deep Exploration
Structured Analysis
Pathway Design
Consolidation & Support
We understand your unique context and the specific challenges your organization faces, through strategic dialogue.
We break down complexity using advanced analytical tools to identify hidden opportunities and risks
We co-create practical solutions and clear evolution paths, tailored to your team's operational reality.
We ensure effective implementation and accessible development of new structures, with ongoing follow-up
2
3
4
Does your organization need to structure, audit, or scale a health initiative?
Schedule an initial diagnostic session without obligation. We will analyze the status of your program and guide you on the appropriate methodology for your challenge.
